Clinical Trial

A Study About Remote and Local Liver Surgery

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if the robotic surgical system producted by Shenzhen Edge Medical Company has a non-inferior textbook outcome in liver surgery in the field of remote surgery compared to local robotic surgery. It will also learn about the safety of remote liver surgery. The main questions are: Does remote liver surgery not lower the textbook outcomes in liver surgery compared to the local robotic surgery? What complications do participants have when taking remote liver surgery? Investigators will compare remote liver surgery to local robotic liver surgery to see if remote liver surgery doesn't lower the textbook outcome in liver surgery. Participants will: Undergo remote or local robotic liver surgery according to the random program; Visit the clinic in 3, 28 and 42 day after surgery for checkups and tests; Keep a diary of their postoperative complications.
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-05-19
notable Enrollment increased: 102 -> 148 participants 2026-05-19
Trial Details
NCT Number NCT07524699
Lead Sponsor Tongji Hospital
Collaborators: The First Medical Center of Chinese PLA General Hospital, The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Affiliated Hospital of Qinghai University, First Affiliated Hospital of Harbin Medical University, Xinqiao Hospital, Amry Medical University, Wuhan TongJi Hospital, Zhujiang Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, First Affiliated Hospital of Chengdu Medical College
Conditions Liver Diseases
Enrollment 148 participants
Start Date 2026-05-16
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-18